000 | 01424 a2200385 4500 | ||
---|---|---|---|
005 | 20250516045642.0 | ||
264 | 0 | _c20120628 | |
008 | 201206s 0 0 eng d | ||
022 | _a1573-4978 | ||
024 | 7 |
_a10.1007/s11033-011-1204-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZalloum, Imad | |
245 | 0 | 0 |
_aGenetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole. _h[electronic resource] |
260 |
_bMolecular biology reports _cApr 2012 |
||
300 |
_a4195-200 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xpharmacokinetics |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
650 | 0 | 4 | _aCytochrome P-450 CYP2C19 |
650 | 0 | 4 | _aDemography |
650 | 0 | 4 |
_aGene Frequency _xgenetics |
650 | 0 | 4 | _aGenetics, Population |
650 | 0 | 4 | _aGenotyping Techniques |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aJordan |
650 | 0 | 4 | _aLansoprazole |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aHakooz, Nancy | |
700 | 1 | _aArafat, Tawfiq | |
773 | 0 |
_tMolecular biology reports _gvol. 39 _gno. 4 _gp. 4195-200 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11033-011-1204-5 _zAvailable from publisher's website |
999 |
_c21016767 _d21016767 |